Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Stephan Beck
  • Professor or Medical Genomics
  • Research Department of Cancer Bio
  • Cancer Institute
  • Faculty of Medical Sciences

Stephan Beck PhD FMedSci is Professor of Medical Genomics at the University College London (UCL) Cancer Institute. Using experimental and computational approaches, his laboratory has broad interests in the genomics and epigenomics of phenotypic plasticity in health and disease. He has over 30 years experience in high-throughput genomics and has co-authored over 250 publications that have attracted over 45,000 citations to date. He received his PhD in 1985 from the University of Konstanz where he studied DNA structure. After appointments at the MRC Laboratory of Molecular Biology in Cambridge, Millipore Corporation in Boston and the Imperial Cancer Research Fund in London, he joined the Wellcome Trust Sanger Institute in 1996. During his tenure as Head of Human Sequencing (1998-2006), he played a leading role in the sequencing and analysis of the human, mouse and zebrafish genomes. He has co-founded and led a number of international efforts, including the Human Epigenome Project and serves on numerous national and international advisory boards.  He is a Fellow of the Academy of Medical Sciences and recipient of a Royal Society Wolfson Research Merit Award.

Research Groups
Research Summary

The laboratory has broad interests in the genomics and epigenomics of phenotypic plasticity in health and disease. In addition to genetic variations, we study epigenetic variations such as DNA methylation, histone modifications and non-coding RNAs and how they modulate genome function. Central to our research is the development systems approaches for integration of multi-dimensional data and their application to epigenome-wide association studies (EWAS) in cancer and other common diseases to advance translational, regenerative and personalized medicine. The Medical Genomics Group offers state-of-the-art facilities and a stimulating environment for graduate and post-doctoral training.

For further details, please visit:  http://www.ucl.ac.uk/cancer/research-groups/medical-genomics/

Teaching Summary

Cancer Epigenetics Module of MSc Cancer Course. The module aims to provide comprehensive insights from bench to bedside for this exiting new discipline of cancer research.

For further details, please visit:  http://www.ucl.ac.uk/cancer/msc-cancer/index.htm

Academic Background
1985 PhD Doctor of Philosophy – Molecular Genetics/Biochemistry Universitat Konstanz
1982 MSc Master of Science – Biology Universitat Konstanz
1979 BSc Bachelor of Science – Biology Universitat Konstanz
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by